The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Epizyme; Lilly
ABI-009 (nab-sirolimus) in advanced malignant perivascular epithelioid cell tumors (PEComa): Preliminary efficacy, safety, and mutational status from AMPECT, an open label phase II registration trial.
 
Andrew J. Wagner
Honoraria - Novartis
Consulting or Advisory Role - Daiichi Sankyo; Five Prime Therapeutics; Lilly; Loxo
Research Funding - AADi (Inst); Celldex (Inst); Daiichi Sankyo (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Plexxikon (Inst)
 
Vinod Ravi
Consulting or Advisory Role - Daiichi Sankyo
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - Author Royalties from Uptodate
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Kristen N. Ganjoo
Consulting or Advisory Role - Daiichi Sankyo; Immune Design; Janssen; Lilly; Novartis
 
Brian Andrew Van Tine
Consulting or Advisory Role - Caris Life Sciences; CytRx Corporation; EMD Serono; Johnson & Johnson; Lilly/ImClone; Novartis; Plexxikon; Threshold Pharmaceuticals
Speakers' Bureau - Caris Life Sciences; Johnson & Johnson; Lilly; Novartis
Research Funding - Merck; Pfizer
Expert Testimony - Me1 Patient
 
Richard F. Riedel
Employment - Biotech Prosthetic Orthotics of North Carolina (I); Limbguard (I)
Leadership - Biotech Prosthetic Orthotics of North Carolina (I); Limbguard (I)
Stock and Other Ownership Interests - Biotech Prosthetic Orthotics of North Carolina (I); Limbguard (I)
Consulting or Advisory Role - Bayer; Bayer; Daiichi Sankyo; Eisai; GlaxoSmithKline; Ignyta; Lilly; Loxo; Merck; NanoCarrier; Novartis
Research Funding - AADi (Inst); Agios (Inst); Arog (Inst); Astex Pharmaceuticals (Inst); Bayer (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Ignyta (Inst); Immune Design (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Merck (Inst); NanoCarrier (Inst); Novartis (Inst); Plexxikon (Inst); Roche/Genentech (Inst); Threshold Pharmaceuticals (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - PandoNet - Limbguard (I)
Travel, Accommodations, Expenses - Daiichi Sankyo; EMD Serono; Ignyta; Janssen; NanoCarrier
 
Rashmi Chugh
Stock and Other Ownership Interests - Portola Pharmaceuticals
Consulting or Advisory Role - EMD Serono; Epizyme; Immune Design; Janssen
Research Funding - AADi (Inst); Advenchen Laboratories (Inst); Epizyme (Inst); MabVax (Inst); Morphotek (Inst); Novartis (Inst); Pfizer (Inst); Plexxikon
 
Lee D. Cranmer
Consulting or Advisory Role - Blueprint Medicines
Research Funding - AADi (Inst); Advenchen Laboratories (Inst); Lilly (Inst)
 
Erlinda Maria Gordon
No Relationships to Disclose
 
Jason L. Hornick
No Relationships to Disclose
 
David J. Kwiatkowski
Consulting or Advisory Role - Genentech/Roche; Novartis
Research Funding - AADi; Genentech/Roche; Revolution Medicines
 
Heng Du
No Relationships to Disclose
 
Berta Grigorian
Employment - AADi
Stock and Other Ownership Interests - AADi
 
Anita N. Schmid
Employment - AADi
Stock and Other Ownership Interests - AADi
 
Shihe Hou
Employment - AADi
Stock and Other Ownership Interests - AADi
 
Katherine Harris
Employment - AADi
 
Neil Desai
Employment - AADi
Leadership - AADi
Stock and Other Ownership Interests - AADi
 
Mark Andrew Dickson
Consulting or Advisory Role - Celgene
Research Funding - Lilly